Health PR
AUS-first digital platform supporting young Aussies living with incurable movement disorder
More than 20,000 young Aussies (under 50 years of age) living with an incurable movement disorder are set to benefit from the launch of an Australian-first digital support platform today (Thursday, April 8, 2021), ahead of World Parkinson’s Day (Sunday, April 11, 2021). Developed as a ‘living lab’ model, the Young Onset Parkinson’s Exchange (YOP-X)…
Read MoreThe critical role of empathy in effective communications
Empathy is key to effective healthcare communication. The ability to put oneself in another’s shoes, trying to understand what they may be feeling, and acknowledging the significant impact an illness or life event can have on a person’s wellbeing is crucial to building trust and connecting in a meaningful way. Every day, the VIVA! team…
Read MoreVIVA! appoints Julia Slater as GM
VIVA! Communications (VIVA!) has today announced the appointment of Julia Slater as General Manager (GM) of the award-winning, independent, Australian health + wellness communications agency and Asia Pacific hub lead for GLOBALHealthPR. Julia brings more than a decade of PR and communications experience to her new role, to support VIVA!’s recent, unparalleled local and international…
Read MoreNew benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
Launch of first pan-Asia Pacific minimum clinical standards for the screening, diagnosis & management of osteoporosis The Asia Pacific Consortium on Osteoporosis (APCO) has today (Thursday, January 28, 2021) launched the first pan-Asia Pacific clinical practice standards for the screening, diagnosis, and management of osteoporosis, targeting a broad range of high-risk groups. Published in Osteoporosis International…
Read MoreCOVID-19 vaccine update
The urgency posed by the COVID-19 pandemic has seen some of the world’s leading research teams working tirelessly to find a vaccine for the virus. Impressively, while most vaccines require years of research and testing, this has facilitated the development of multiple COVID-19 vaccines in a matter of months, with many trials still in progress.…
Read More